By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Diagnostics will provide genetically defined human cell line reference standards for distribution to molecular diagnostic laboratories worldwide under a deal with the European Molecular Genetics Quality Network (EMQN) announced today.

The cell line references will be distributed as part of EMQN's annual external quality assessment schemes to ensure sensitivity and reproducibility of diagnostic assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.